MedTrace Logo

Probiotic Intervention for People With Multiple Sclerosis

NCT07304713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2025-12-26

No results posted yet for this study

Summary

The goal of this single-arm, mixed methods trial is to learn if it is feasible and acceptable to take a probiotic for 12-weeks in people with Multiple Sclerosis. The main question\[s\] it aims to answer \[is/are\]:

* Is it feasible and acceptable for people with MS to take a probiotic for 12-weeks?
* Explore impact on health outcomes? Participants will.
* Drink 70ml probiotic drink daily as prescribed for 12-weeks.
* All data collection will be done remotely.
* Before and after 12-weeks participants will complete an online questionnaire (Acceptability, lifestyle behaviour, symptoms, quality of life).
* Provide a stool sample to analyse microbiome changes.
* Take a short online cognitive test.
* Participate in a focus group.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

12-week probiotic intervention (70ml daily)

Sponsors & Collaborators

  • Sheffield Hallam University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2023-11-24
Completion
2023-11-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07304713 on ClinicalTrials.gov